Literature DB >> 16750274

Neurological abnormalities in caveolin-1 knock out mice.

Eugenia Trushina1, Jordan Du Charme, Joseph Parisi, Cynthia T McMurray.   

Abstract

Caveolin-1 is the defining structural protein in caveolar vesicles, which regulate signal transduction and cholesterol trafficking in cells. In the brain, cav-1 is highly expressed in neurons and glia, but its function in those cell types is unclear. Mice deficient in cav-1 (CavKO) have been developed to test functional roles for cav-1 in various tissues. However, neurological phenotypes associated with loss of cav-1 in mice have not been evaluated. Here, we report the results of motor and behavioral testing of CavKO mice. We find that mice deficient in cav-1 have reduced brain weight and display a number of motor and behavioral abnormalities. CavKO mice develop neurological phenotypes including clasping, abnormal spinning, muscle weakness, reduced activity, and gait abnormalities. These data suggest that cav-1 is involved in maintaining cortico-striato-pallido-thalamo-pontine pathways associated with motor control.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16750274     DOI: 10.1016/j.bbr.2006.04.024

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  36 in total

1.  Loss of caveolin-1 expression in knock-in mouse model of Huntington's disease suppresses pathophysiology in vivo.

Authors:  Eugenia Trushina; Christie A Canaria; Do-Yup Lee; Cynthia T McMurray
Journal:  Hum Mol Genet       Date:  2013-09-10       Impact factor: 6.150

2.  Do studies in caveolin-knockouts teach us about physiology and pharmacology or instead, the ways mice compensate for 'lost proteins'?

Authors:  P A Insel; H H Patel
Journal:  Br J Pharmacol       Date:  2006-12-18       Impact factor: 8.739

3.  Synthesis and pharmacological evaluation of 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a cocaine antagonist, in rodents.

Authors:  Nidhi Kaushal; Matthew J Robson; Harsha Vinnakota; Sanju Narayanan; Bonnie A Avery; Christopher R McCurdy; Rae R Matsumoto
Journal:  AAPS J       Date:  2011-04-15       Impact factor: 4.009

4.  Caveolin-1 knockout mice exhibit impaired induction of mGluR-dependent long-term depression at CA3-CA1 synapses.

Authors:  Yukihiro Takayasu; Koichi Takeuchi; Ranju Kumari; Michael V L Bennett; R Suzanne Zukin; Anna Francesconi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-23       Impact factor: 11.205

Review 5.  Caveolae as organizers of pharmacologically relevant signal transduction molecules.

Authors:  Hemal H Patel; Fiona Murray; Paul A Insel
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

Review 6.  Caveolin proteins and estrogen signaling in the brain.

Authors:  Jessie I Luoma; Marissa I Boulware; Paul G Mermelstein
Journal:  Mol Cell Endocrinol       Date:  2008-04-22       Impact factor: 4.102

7.  Involvement of caveolin-1 in neurovascular unit remodeling after stroke: Effects on neovascularization and astrogliosis.

Authors:  Camille Blochet; Lara Buscemi; Tifenn Clément; Sabrina Gehri; Jérôme Badaut; Lorenz Hirt
Journal:  J Cereb Blood Flow Metab       Date:  2018-10-24       Impact factor: 6.200

8.  Impact of the loss of caveolin-1 on lung mass and cholesterol metabolism in mice with and without the lysosomal cholesterol transporter, Niemann-Pick type C1.

Authors:  Dorothy I Mundy; Adam M Lopez; Kenneth S Posey; Jen-Chieh Chuang; Charina M Ramirez; Philipp E Scherer; Stephen D Turley
Journal:  Biochim Biophys Acta       Date:  2014-04-18

Review 9.  From embryonic development to human diseases: The functional role of caveolae/caveolin.

Authors:  Jihee Sohn; Rachel M Brick; Rocky S Tuan
Journal:  Birth Defects Res C Embryo Today       Date:  2016-03-17

10.  Type-1 cannabinoid receptors colocalize with caveolin-1 in neuronal cells.

Authors:  Monica Bari; Sergio Oddi; Chiara De Simone; Paola Spagnolo; Valeria Gasperi; Natalia Battista; Diego Centonze; Mauro Maccarrone
Journal:  Neuropharmacology       Date:  2007-07-20       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.